News
US pharmaceutical giant Eli Lilly said on Wednesday the Therapeutic Goods Administration (TGA) had approved the use of its ...
Tariffs on pharmaceutical imports could hurt Lilly, especially with its dependence on products made in Ireland. The president ...
7d
Pharmaceutical Technology on MSNEli Lilly to expand pain pipeline with $1bn SiteOne buyoutThe deal tees up a pain treatment market rivalry with Vertex Pharmaceuticals as the industry starts to move away from opioids ...
The acquisition expands Lilly’s pain pipeline with a slate of drugs targeting ion channel proteins like NaV1.7 and NaV1.8.
Eli Lilly will buy privately held SiteOne Therapeutics in a deal worth as much as $1 billion, the companies said on Tuesday, ...
In collaboration with Eli Lilly and Company (NYSE:LLY), a pharmaceutical company recognized globally for its innovative ...
I think, though, that Lilly (and other big pharmaceutical companies) will be able to successfully navigate the murky waters regardless of what happens. Keith Speights has no position in any of the ...
2d
Barchart on MSNEli Lilly vs. Novo Nordisk: Which Stock Is the Winner of the Weight-Loss Drug Boom?The global weight-loss drug market is experiencing exceptional growth, projected to expand from around $144.6 billion in 2023 ...
5d
Barchart on MSNIs Eli Lilly and Company Stock Underperforming the Dow?With a market cap of $681.8 billion, Eli Lilly and Company (LLY) is a leading global pharmaceutical company focused on ...
I think, though, that Lilly (and other big pharmaceutical companies) will be able to successfully navigate the murky waters regardless of what happens. The Motley Fool Stock Advisor analyst team ...
Let's consider two corporations that could help you do better than average in the next decade: Eli Lilly (NYSE: LLY) and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results